An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) has appointed William J. Coote as Vice President, Chief Financial Officer, and Chief Accounting Officer, effective immediately. Mr. Coote brings over 25 years of financial executive experience, having served as Taro's AVP, Treasurer, and Business Finance since 2008. His previous roles include positions at Bowne & Co., Prudential Realty, Merrill Lynch, and Ernst & Young.
CEO Uday Baldota expressed confidence in Coote's leadership, highlighting his track record and experience as vital for executing the company's strategy.
Positive
William J. Coote's appointment brings continuity and strong financial leadership.
Coote has extensive experience in financial roles, expected to benefit Taro's strategic execution.
Negative
None.
HAWTHORNE, N.Y.--(BUSINESS WIRE)--
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) today announced the appointment of William J. Coote as Vice President, Chief Financial Officer and Chief Accounting Officer, effective today.
Mr. Coote has over 25 years of significant financial executive experience; most recently serving as Taro’s AVP, Treasurer and Business Finance since 2008.
Prior to joining Taro, Mr. Coote has held progressively responsible positions with a variety of global companies such as Bowne & Co., Prudential Realty, Merrill Lynch, and Ernst & Young. Throughout his career, he has been accountable for areas such as: Accounting, Treasury, Budgeting, Financial Planning and Analysis, Acquisitions, Investor Relations, Financial and SEC Reporting.
Regarding the appointment, Mr. Uday Baldota, Taro’s CEO, commented, “I am excited to have Bill lead our financial and accounting teams at Taro. Bill is a successful Taro leader; he brings a strong track record of accomplishment and diversified experience, combined with continuity, as we execute on our strategy.”
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
